The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial

The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial

Abstract Background In-centre nocturnal haemodialysis (INHD) offers extended-hours haemodialysis, 6 to 8 h thrice-weekly overnight, with the support of dialysis specialist nurses. There is increasing observational data demonstrating potential benefits of INHD on health-related quality of life (HRQoL...

Full description

Bibliographic Details
Main Authors: Katherine L. Hull, Kate Bramham, Cassandra L. Brookes, Victoria Cluley, Carmel Conefrey, Nicola J. Cooper, Helen Eborall, James Fotheringham, Matthew P. M. Graham-Brown, Laura J. Gray, Patrick B. Mark, Sandip Mitra, Gavin J. Murphy, Niamh Quann, Leila Rooshenas, Madeleine Warren, James O. Burton
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Trials
Subjects:
In-centre nocturnal haemodialysis
End-stage kidney disease
Quality of life
Cost-effectiveness
Online Access:https://doi.org/10.1186/s13063-023-07565-w

Similar Items

Similar Items